Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

HeartBeam Announces FDA Submission Of HeartBeam AIMI Product

Submission Seeks Approval for the Company's Proprietary ECG Technology to Aid in Diagnosis of Heart Attack in $500 million Total Addressable Market 18+ million People in the US have Coronary Artery DiseaseSubmission Seeks Approval for the Company's Proprietary ECG Technology to Aid in Diagnosis of Heart Attack in $500 million Total Addressable Market

BEAT